EdU assays demonstrated that the rates of proliferation of MCT-PAH-PASMCs were increased compared with that of Ctrl-PASMCs and were inhibited by silencing ZIP12 (Fig. 3A). The gene discussed is SLC39A12; the disease is pulmonary arterial hypertension.